Clinical trials: Blood Glucose Self Monitoring
Diabetes Mellitus, Type 2
Self Titration With Apidra to Reach Target Study (START)
Primary Objective: The primary objective of this study is to demonstrate non-inferiority of a patient-managed titration algorithm (including blood glucose monitoring) for the addition of a single dose of insulin glulisine at…
- Trial name
- NCT01013571
- Testing
- insulin glargine, Apidra (insulin glulisine)
- Where
- Canada
- Volunteers
- 493 people
- Sponsor
- Sanofi
Type 2 Diabetes
Blood Glucose Monitoring on Behavior Change in Type 2 Diabetes
This purpose of this study is to investigate the effect of the self-regulation mode of continuous blood glucose monitoring on blood glucose indicators, self-efficacy, health-promoting behaviors, and medication compliance in…
- Trial name
- NCT05367622
- Testing
- Self-regulation health education, Usual diabetes health education
- Where
- Taiwan
- Volunteers
- 60 people
- Sponsor
- Chang Gung University of Science and Technology
Diabetes Mellitus, Type 2, Coronary Artery Disease
SMBG Protocols Predicting Glucose Levels in Senior Diabetes Mellitus With CAD
Self-monitoring of blood glucose (SMBG) is a common way to assess glycemic control in diabetes management. Multiple times of blood glucose measurements by fingerstick in the same day are of tough challenge to it.
- Trial name
- NCT01954771
- Testing
- SMBG, CGMS
- Where
- China
- Volunteers
- 89 people
- Sponsor
- Beijing Anzhen Hospital
Gestational Diabetes Mellitus in Pregnancy
Effectiveness of CGMS Vs. Self-monitoring Blood Glucose (SMBG) in Woman with Gestational Diabetes
The detection of and control of gestational diabetes carries benefits for both mother and baby related to immediate pregnancy outcomes.
- Trial name
- STEADYSUGAR (NCT04948112)
- Testing
- real time continuous glucose monitor, blinded continuous glucose monitor
- Where
- United States
- Volunteers
- 128 people
- Sponsor
- Woman's
Diabetes Mellitus, Type 1, Diabetes Mellitus, Insulin-Dependent
Telemetric Glucose Data Acquisition During Initiation of Insulin Pump Therapy
This study will help determine whether the use of a wireless glucose meter and and an internet-based automated diabetes management system to organize blood glucose values will help improve glucose control during the start of…
- Trial name
- NCT00297635
- Testing
- GlucoDYNAMIX™ intervention system, GlucoMON™ telemetry device
- Sponsor
- Thomas Jefferson University
Diabetes Mellitus
Performance Evaluation of Blood Glucose Monitoring Systems
The goal of this single-center, comparative, open label, in-vitro diagnostic device performance evaluation was to investigate the performance of two sanofi-aventis BGMSs (BGStar® and iBGStar®) with regard to system accuracy…
- Trial name
- Polaris (NCT01504620)
- Testing
- Sugar infusion, insulin infusion
- Where
- Germany
- Volunteers
- 106 people, healthy volunteers welcome
- Sponsor
- IKFE Institute for Clinical Research and Development
Type 1 Diabetes Mellitus, Type 2 Diabetes Mellitus
Clinical Study to Evaluate the Impact of the Accu-Chek SmartGuide CGM Solution on the Mean Change in Time in Range Compared With Self-Monitoring of Blood Glucose in Participants With Type 1 and Type 2 Diabetes Mellitus
This is an open label, two-arm, randomized multi-center clinical device study in adult subjects with Type 1 diabetes (T1D) or insulin-dependent Type 2 diabetes (T2D) on a multiple daily injection (MDI) regime.
- Trial name
- NCT06704672
- Testing
- Accu-Chek SmartGuide CGM Solution, Accu-Chek SmartGuide Sensor and Blinded Apps, SMBG Device
- Where
- 20 sites in Poland, Turkey (Türkiye)
- Volunteers
- 270 people
- Sponsor
- Hoffmann-La Roche
Diabetes Mellitus, Type 1
The GlucoPred Investigation II
Diabetes mellitus type 1 (DM1) is an autoimmune metabolic disease in which the insulin producing cells in the pancreas are destroyed and the subject is left totally dependent of external supply of insulin.
- Trial name
- GPI-II (NCT02595580)
- Testing
- Glucopred
- Where
- 2 sites in Norway
- Volunteers
- 16 people
- Sponsor
- Norwegian University of Science and Technology
Diabetes Mellitus, Type 2
Self-Care for Older People With Diabetes Mellitus
In Singapore, the prevalence of diabetes was approximately 12.8% in 2014 and was projected to rise to 22.7% in 2035. In 2015, the International Diabetes Federation (IDF) reported that Singapore has the second highest proportion…
- Trial name
- SCOPE-DM (NCT03890991)
- Testing
- SCOPE-DM, SCOPE-DM with 3 months' supply of glucometer, SCOPE-DM with 6 months' supply of glucometer
- Where
- Singapore
- Volunteers
- 320 people
- Sponsor
- National University of Singapore
Type 2 Diabetes
Patients and Care Providers Perspectives and Experience With Decision Aid Tool for Self-monitoring of Blood Glucose
Putting the limited use of titration algorithms in the context of escalating diabetes prevalence rates, strategies and tools are urgently needed to help both patients and primary care providers efficiently initiate and continue…
- Trial name
- NCT02553408
- Testing
- FreeStyle Precision Neo-Meter
- Where
- Canada
- Volunteers
- 16 people
- Sponsor
- London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's
Diabetes Mellitus, Type 2
Glucose Monitoring Comparison in Primary Care
This research trial will randomize 50 primary care clinics and 354 patients in accordance with their primary care clinic assignment to 2 different glucose monitoring strategies (SMBG vs.
- Trial name
- GluCoCare (NCT05222815)
- Testing
- CGM, SMBG
- Where
- United States
- Volunteers
- 360 people
- Sponsor
- HealthPartners Institute
Diabetes Mellitus, Type 1
AHCL System Initiation in T1D Patients naïve to Technology
The primary objective of this study is to evaluate whether the MiniMed 780G AHCL system improves glycemic control and Quality of Life (QoL) perception in adult individuals with T1D and naïve to CSII and CGM technologies.
- Trial name
- NCT04616391
- Testing
- insulin pump Medtronic 780G
- Volunteers
- 40 people
- Sponsor
- Jagiellonian University
Diabetes
System Accuracy and User Performance of Blood Glucose Monitoring Systems for Self-Testing in Managing Diabetes Mellitus
The aim of this test is to determine the system accuracy and user performance evaluation of three Blood Glucose Monitoring systems.
- Trial name
- NCT02290067
- Testing
- Blood glucose monitoring system (Omnitest 3), Blood glucose monitoring system (Omnitest 5), Blood glucose monitoring system (Omnitest 5D)
- Where
- Germany
- Volunteers
- 130 people, healthy volunteers welcome
- Sponsor
- B. Braun Melsungen AG
Type 2 Diabetes Mellitus
A Study to Compare the Use of Diabetes Treatment Support System (BAP0527 and Blood Glucose Meter) in Addition to Daily Practice and Treatment With Daily Practice and Treatment Alone in Patients With Type 2 Diabetes Mellitus
The subjects of this study are patients with type 2 diabetes mellitus. The patients take part in dietetic therapy and exercise therapy, and also receive diabetes education to improve lifestyle habits, but since diet and exercise…
- Trial name
- NCT06156696
- Testing
- BAP0527, Blood Glucose Meter
- Where
- Japan
- Volunteers
- 248 people
- Sponsor
- Astellas Pharma Inc
Diabetes Mellitus, Type 2
HbA1c Prediction Model in Patients With Type 2 Diabetes
Patients with type 2 diabetes who have poor blood glucose control are enrolled to evaluate the efficacy and safety of the HbA1c prediction model for adjust the hypoglycemic treatment regimen, compared with the conventional…
- Trial name
- NCT05824286
- Testing
- HbA1c prediction
- Where
- China
- Volunteers
- 150 people
- Sponsor
- Peking University People's Hospital
Diabetes Mellitus, Type 2
Acceptability & Impact of a Diabetes Management Smartphone App (mySugr) for Spanish-literate Adults With Type 2 Diabetes
The goal of this clinical trial is to compare those using a diabetes management smartphone application (mySugr) to those not using the application.
- Trial name
- mySugr (NCT05975242)
- Testing
- Smartphone diabetes management application
- Where
- United States
- Volunteers
- 32 people
- Sponsor
- Sansum Diabetes Research Institute
Diabetes Mellitus, Type 1, Blood Glucose
Accuracy of Two CGM Systems Tested Simultaneously in Ambulatory Patients With Type 1 Diabetes
Continuous glucose monitoring (CGM) is a tool used in the treatment of patients with type 1 diabetes. A continuous glucose monitor (CGM) is a subcutaneous tissue sensor, which provides a tissue fluid glucose measurement every 1…
- Trial name
- NCT02159638
- Testing
- Guardian Enlite sensor, Dexcom G4 platinum sensor
- Where
- 2 sites in Sweden
- Volunteers
- 38 people
- Sponsor
- Vastra Gotaland Region
Type 2 Diabetes, Telemedicine
Telemedicine Influence in the Follow up of the Type 2 Diabetes Patient
The purpose of this study is to evaluate the impact of a a real time teleassistance system in the clinical evolution of type 2 diabetic patients on self monitoring blood glucose in the Public National Primary Care System.
- Conditions
- Type 2 Diabetes, Telemedicine, Self Monitoring Blood Glucose, Primary Care
- Trial name
- NCT00527254
- Testing
- Telemedicine system
- Where
- Spain
- Volunteers
- 328 people
- Sponsor
- Province of Malaga Health Department
Diabetes (DM)
RIGHTEST iFree 2 CGM System for Glycemic Control in Adults With Diabetes Mellitus
The goal of this clinical trial is to find out whether using a real-time continuous glucose monitoring (CGM) system can improve daily blood sugar control compared with usual self-monitoring of blood glucose (SMBG; finger-stick…
- Trial name
- NCT07889375
- Testing
- Continuous Glucose Monitoring (CGM), Self-monitoring of blood glucose (SMBG)
- Where
- Taiwan
- Volunteers
- 324 people
- Sponsor
- Bionime Corporation
Type 2 Diabetes
The Evaluation of Laser Lancing Devices in Adult Type 2 Diabetes Patients
Self monitoring of blood glucose level is crucial in diabetes management, but currently available methods, lancet, have shown low compliance of self monitoring of blood glucose because of pain, keratinization of finger tip…
- Trial name
- NCT05251506
- Testing
- laser lancing device or lancet for blood glucose level measurement
- Where
- South Korea
- Volunteers
- 80 people
- Sponsor
- Korea University Guro Hospital